• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Blood Grouping Reagents Market Research Report - Global Forecast till 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Blood Grouping Reagents Market

    ID: MRFR/HC/9241-CR
    142 Pages
    Rahul Gotadki
    November 2021

    Blood Grouping Reagents Market Research Report Information by Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Blood Grouping Reagents Market Research Report - Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Blood Grouping Reagents Market Summary

    As per Market Research Future Analysis, the global Blood Grouping Reagents Market is projected to reach USD 0.0020 billion by 2032, growing at a CAGR of 7.6% from 2023 to 2032. The market was valued at USD 1,578.78 million in 2020. Blood grouping reagents are essential for identifying blood types based on antigens present on red blood cells. The market is driven by the rising prevalence of chronic disorders and increased spending on medical research, although concerns regarding the efficiency of test kits pose challenges. The COVID-19 pandemic has further amplified the demand for blood grouping reagents due to the surge in diagnostic testing requirements. The market is segmented by product, technique, test type, end user, and region, with significant growth opportunities in automated blood grouping devices.

    Key Market Trends & Highlights

    Key trends influencing the Blood Grouping Reagents Market include technological advancements and increasing demand for automation.

    • Market size in 2020: USD 1,578.78 million.
    • Projected market size by 2032: USD 0.0020 billion.
    • CAGR during 2023-2032: 7.6%.
    • Anemia affects over 1.62 billion people globally, driving reagent demand.

    Market Size & Forecast

    2020 Market Size USD 1,578.78 million
    2032 Market Size USD 0.0020 billion
    CAGR 7.6%

    Major Players

    Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), Novacyt Group (France), Beckman Coulter, Inc (US), Grifols SA (Spain), Immucor, Inc (US)

    Blood Grouping Reagents Market Trends

    The ongoing advancements in blood grouping reagents are likely to enhance diagnostic accuracy and improve patient outcomes in transfusion medicine.

    U.S. Food and Drug Administration (FDA)

    Blood Grouping Reagents Market Drivers

    Market Trends and Projections

    Regulatory Support for Blood Safety

    Regulatory bodies worldwide are increasingly emphasizing the importance of blood safety, which significantly impacts the Global Blood Grouping Reagents Market Industry. Stringent regulations regarding blood testing and safety protocols necessitate the use of high-quality reagents for accurate blood typing. Compliance with these regulations ensures that healthcare providers can deliver safe transfusions, thereby enhancing patient outcomes. As regulations evolve, the market is likely to adapt, leading to innovations in reagent development. This regulatory landscape not only supports market growth but also reinforces the commitment to patient safety in transfusion practices.

    Rising Demand for Blood Transfusions

    The Global Blood Grouping Reagents Market Industry experiences a notable increase in demand for blood transfusions, driven by a growing prevalence of chronic diseases and surgical procedures. As healthcare systems worldwide expand their capabilities, the need for accurate blood typing becomes paramount. In 2024, the market is projected to reach 0.11 USD Billion, reflecting the urgency for reliable reagents in transfusion medicine. This trend is expected to continue, with the market adapting to the rising number of transfusions required annually, thereby enhancing the overall efficiency of blood banks and hospitals.

    Increasing Awareness of Blood Donation

    The Global Blood Grouping Reagents Market Industry benefits from heightened awareness regarding the importance of blood donation. Campaigns aimed at educating the public about the need for diverse blood types have led to increased participation in blood donation drives. This surge in donations necessitates the use of effective blood grouping reagents to ensure compatibility and safety. As more individuals engage in donating blood, the demand for reliable reagents is expected to rise, thereby supporting the growth of the market. This trend underscores the critical role of education in fostering a culture of donation.

    Market Challenges and Declining Growth Rates

    Despite the growth potential, the Global Blood Grouping Reagents Market Industry faces challenges that may hinder its expansion. Projections indicate a compound annual growth rate (CAGR) of -29.29% for the period from 2025 to 2035, suggesting a decline in market activity. Factors contributing to this trend may include saturation in certain regions and the emergence of alternative technologies. As the market navigates these challenges, stakeholders must adapt their strategies to maintain relevance and ensure sustainability in a rapidly changing healthcare landscape.

    Technological Advancements in Blood Grouping

    Technological innovations play a crucial role in shaping the Global Blood Grouping Reagents Market Industry. The introduction of automated blood grouping systems and advanced reagents enhances accuracy and reduces turnaround times in blood typing processes. These advancements not only improve patient safety but also streamline laboratory workflows. As healthcare facilities increasingly adopt these technologies, the market is likely to witness a surge in demand for high-quality reagents. This trend indicates a shift towards more sophisticated blood grouping solutions, which could potentially lead to a more efficient healthcare delivery system.

    Market Segment Insights

    Regional Insights

    Key Companies in the Blood Grouping Reagents Market market include

    Industry Developments

    Future Outlook

    Blood Grouping Reagents Market Future Outlook

    The Blood Grouping Reagents Market is projected to experience a -29.29% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for blood transfusions, and regulatory changes.

    New opportunities lie in:

    • Develop innovative, cost-effective reagents to enhance market penetration.
    • Leverage digital platforms for efficient distribution and customer engagement.
    • Invest in R&D for next-generation blood grouping technologies to gain competitive edge.

    By 2035, the market is expected to stabilize, adapting to evolving healthcare demands and technological advancements.

    Market Segmentation

    Report Scope

    Report Attribute/Metric Details
      Market Size   0.0020 Billion
      CAGR   7.6%
      Base Year   2021
      Forecast Period   2023-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Products, Technique, Test Type, End User, and Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
      Key Vendors   Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), Novacyt Group (France), Beckman Coulter, Inc (US), Haemokinesis Pty Ltd (Australia), MTC Med. Produkte GmbH (Germany), DAY medical SA (Switzerland), Rapid Labs Ltd (UK), Ortho Clinical Diagnostics (US), Diagast SAS (France), and others
      Key Market Opportunities   • Emergence of automated medical devices
      Key Market Drivers   • Increasing prevalence of chronic disorders • Increasing spending in medical research

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How Big is the blood grouping reagents market?

    Blood Grouping Reagents Market size is projected to be worth USD 0.0020 billion at CAGR of 7.6% during the forecast period (2023 - 2032), The market was valued at USD 1,578.78 million in 2020.

    Who are the key players in the market of blood grouping reagents?

    Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), Novacyt Group (France), Beckman Coulter, Inc (US), Haemokinesis Pty Ltd (Australia), MTC Med. Produkte GmbH (Germany), DAY medical SA (Switzerland), Rapid Labs Ltd (UK), Ortho Clinical Diagnostics (US), Diagast SAS (France) are the key players in the market of blood grouping reagents

    Which region is predicted to lead the market of blood grouping reagents?

    North America holds the largest share in the global market of lood grouping reagents

    What is the major market driver of blood grouping reagents?

    Increasing prevalence of chronic disorders and Increasing spending in medical research are the major market driver of blood grouping reagents

    Which factors may limit the market growth of blood grouping reagents?

    Concern pertaining to the efficiency and accuracy of test kits may limit the market growth of blood grouping reagents

    1. EXECUTIVE SUMMARY
    2. MARKET INTRODUCTION
      1. SCOPE OF THE STUDY
      2. RESEARCH OBJECTIVE
      3. MARKET STRUCTURE
      4. ASSUMPTIONS & LIMITATIONS
    3. RESEARCH METHODOLOGY
      1. DATA MINING
      2. SECONDARY RESEARCH
      3. PRIMARY RESEARCH
      4. BREAKDOWN OF PRIMARY
    4. RESPONDENTS
      1. FORECASTING TECHNIQUES
      2. RESEARCH METHODOLOGY FOR MARKET
    5. SIZE ESTIMATION
      1. BOTTOM-UP APPROACH
        1. TOP-DOWN APPROACH
    6. DATA TRIANGULATION
      1. VALIDATION
    7. MARKET DYNAMICS
      1. OVERVIEW
      2. DRIVERS
        1. INCREASING PREVALENCE OF CHRONIC DISORDERS
        2. INCREASING
    8. SPENDING IN MEDICAL RESEARCH
      1. RESTRAINT
        1. CONCERNS PERTAINING TO
    9. THE EFFICIENCY AND ACCURACY OF TEST KITS
      1. OPPORTUNITY
        1. EMERGENCE
    10. OF AUTOMATED BLOOD GROUPING DEVICES
      1. TECHNOLOGICAL DISRUPTION
    11. MARKET FACTOR ANALYSIS
      1. VALUE CHAIN ANALYSIS
        1. R&D AND DESIGNING
        2. MANUFACTURING
        3. DISTRIBUTION & SALES
        4. POST-SALES
    12. REVIEW
      1. PORTER'S FIVE FORCES MODEL
        1. BARGAINING POWER OF BUYERS
        2. BARGAINING POWER OF SUPPLIERS
        3. THREAT OF NEW ENTRANTS
    13. THREAT OF SUBSTITUTES
      1. INTENSITY OF RIVALRY
      2. IMPACT OF COVID-19
        1. IMPACT ON DEMAND
        2. IMPACT ON SUPPLY CHAIN
      3. VOLUME OF TESTS
    14. FOR DONATED BLOOD, BY REGION, 2020
      1. BLOOD TRANSFUSION VOLUME, BY REGION,
    15. GLOBAL BLOOD GROUPING REAGENTS, BY PRODUCT
      1. OVERVIEW
    16. CONSUMABLES
      1. INSTRUMENTS
        1. FULLY-AUTOMATED INSTRUMENTS
    17. SEMI-AUTOMATED INSTRUMENTS
    18. GLOBAL BLOOD GROUPING REAGENTS, BY TECHNIQUE
      1. OVERVIEW
      2. PCR-BASED AND MICROARRAY TECHNIQUE
      3. ASSAY-BASED
    19. TECHNIQUES
      1. MASSIVELY PARALLEL SEQUENCING TECHNIQUES
      2. SEROLOGY
        1. GEL TECHNIQUE
        2. EMT
        3. SPRCA
        4. GLASS SLIDE AND
    20. TUBES
      1. CASSETTE/KIT
        1. OTHER SEROLOGY
      2. OTHER TECHNIQUES
    21. GLOBAL BLOOD GROUPING REAGENTS, BY TEST TYPE
      1. OVERVIEW
      2. BLOOD
    22. GROUP AND PHENOTYPES
      1. ANTIBODY SCREENING
      2. CROSSMATCHING TESTS
      3. ANTIBODY IDENTIFICATION
      4. COOMBS TEST
      5. ANTIGEN TYPING
    23. GLOBAL BLOOD GROUPING REAGENTS, BY END USER
      1. OVERVIEW
      2. HOSPITALS
      3. BLOOD BANKS
      4. CLINICAL LABORATORIES
    24. GLOBAL BLOOD GROUPING REAGENTS
    25. MARKET, BY REGION
      1. OVERVIEW
      2. NORTH AMERICA
        1. US
    26. CANADA
      1. EUROPE
        1. GERMANY
        2. UK
        3. FRANCE
        4. SPAIN
        5. ITALY
        6. REST OF EUROPE
      2. ASIA PACIFIC
        1. CHINA
        2. JAPAN
        3. INDIA
        4. SOUTH KOREA
    27. AUSTRALIA
      1. REST OF ASIA-PACIFIC
      2. REST OF THE WORLD
    28. MIDDLE EAST
      1. AFRICA
        1. LATIN AMERICA
    29. COMPETITIVE LANDSCAPE
      1. COMPETITIVE OVERVIEW
      2. MAJOR PLAYERS IN THE GLOBAL BLOOD GROUPING
    30. REAGENTS MARKET
      1. MAJOR GROWTH STRATEGIES IN THE GLOBAL BLOOD GROUPING REAGENTS
    31. MARKET
      1. COMPETITIVE BENCHMARKING
      2. LEADING PLAYERS IN TERMS OF
    32. NUMBER OF DEVELOPMENTS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
      1. KEY
    33. DEVELOPMENTS & GROWTH STRATEGIES
      1. NEW PRODUCT DEVELOPMENTS/LAUNCHES
        1. COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS
      2. MAJOR PLAYERS
    34. FINANCIAL MATRIX
      1. REVENUE OF MAJOR PLAYERS, 2020
        1. R&D
    35. EXPENDITURE
    36. COMPANY PROFILES
      1. MERCK KGAA
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      2. BIO-RAD LABORATORIES,
    37. INC.
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
        2. PRODUCTS
    38. OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY STRATEGIES
      2. NOVACYT GROUP
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. KEY
    39. STRATEGIES
      1. BECKMAN COULTER, INC.
        1. COMPANY OVERVIEW
    40. FINANCIAL OVERVIEW
      1. PRODUCTS OFFERED
        1. KEY DEVELOPMENTS
        2. KEY STRATEGIES
      2. HAEMOKINESIS PTY LTD
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. KEY STRATEGIES
      3. MTC MED. PRODUKTE GMBH
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY
    41. DEVELOPMENTS
      1. KEY STRATEGIES
      2. DAY MEDICAL SA
        1. COMPANY
    42. OVERVIEW
      1. FINANCIAL OVERVIEW
        1. PRODUCTS OFFERED
    43. KEY DEVELOPMENTS
      1. KEY STRATEGIES
      2. RAPID LABS LTD
    44. COMPANY OVERVIEW
      1. FINANCIAL OVERVIEW
        1. PRODUCTS OFFERED
        2. KEY DEVELOPMENTS
        3. KEY STRATEGIES
      2. ORTHO CLINICAL DIAGNOSTICS
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS OFFERED
        4. KEY DEVELOPMENTS
        5. SWOT ANALYSIS
        6. KEY STRATEGIES
      3. DIAGAST SAS
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. KEY
    45. STRATEGIES
      1. GRIFOLS SA
        1. COMPANY OVERVIEW
        2. FINANCIAL
    46. OVERVIEW
      1. PRODUCTS/SERVICES OFFERED
        1. KEY DEVELOPMENTS
        2. SWOT ANALYSIS
        3. KEY STRATEGIES
      2. IMMUCOR, INC.
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES
    47. OFFERED
      1. KEY DEVELOPMENTS
        1. SWOT ANALYSIS
        2. KEY
    48. STRATEGIES
      1. QUOTIENT LTD
        1. COMPANY OVERVIEWS
        2. FINANCIAL
    49. OVERVIEW
      1. PRODUCTS/SERVICES OFFERED
        1. KEY DEVELOPMENTS
        2. SWOT ANALYSIS
        3. KEY STRATEGIES
      2. YUVRAJ BIOBIZ INCUBATOR
    50. INDIA PVT LTD
      1. COMPANY OVERVIEW
        1. FINANCIAL OVERVIEW
    51. PRODUCTS/SERVICES OFFERED
      1. KEY DEVELOPMENTS
        1. KEY STRATEGIES
      2. TULIP DIAGNOSTICS
        1. COMPANY OVERVIEW
        2. FINANCIAL OVERVIEW
        3. PRODUCTS/SERVICES OFFERED
        4. KEY DEVELOPMENTS
        5. KEY
    52. STRATEGIES
      1. AIKANG
        1. COMPANY OVERVIEW
        2. FINANCIAL
    53. OVERVIEW
      1. PRODUCTS/SERVICES OFFERED
        1. KEY DEVELOPMENTS
        2. KEY STRATEGIES
      2. INTEC
        1. COMPANY OVERVIEW
    54. FINANCIAL OVERVIEW
      1. PRODUCTS OFFERED
        1. KEY DEVELOPMENTS
        2. KEY STRATEGIES
    55. APPENDIX
      1. REFERENCES
      2. RELATED
    56. REPORTS
    57. OF TRANSFUSION-TRANSMISSIBLE INFECTIONS IN BLOOD DONATIONS (MEDIAN, INTERQUARTILE
    58. RANGE (IQR)), BY INCOME GROUPS
    59. GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022–2030 (USD MILLION)
    60. (USD MILLION)
    61. BY REGION, 2022–2030 (USD MILLION)
    62. MARKET, FOR INSTRUMENTS, BY TYPE, 2022–2030 (USD MILLION)
    63. BLOOD GROUPING REAGENTS MARKET, FOR FULLY-AUTOMATED, BY REGION, 2022–2030
    64. (USD MILLION)
    65. BY REGION, 2022–2030 (USD MILLION)
    66. MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)
    67. GROUPING REAGENTS MARKET, FOR PCR-BASED AND MICROARRAY TECHNIQUE, BY REGION, 2022–2030
    68. (USD MILLION)
    69. TECHNIQUES, BY REGION, 2022–2030 (USD MILLION)
    70. GROUPING REAGENTS MARKET, FOR MASSIVELY PARALLEL SEQUENCING TECHNIQUES, BY REGION,
    71. –2030 (USD MILLION)
    72. FOR SEROLOGY, BY REGION, 2022–2030 (USD MILLION)
    73. GROUPING REAGENTS MARKET, FOR SEROLOGY, BY TYPE, 2022–2030 (USD MILLION)
    74. –2030 (USD MILLION)
    75. FOR EMT, BY REGION, 2022–2030 (USD MILLION)
    76. REAGENTS MARKET, FOR SPRCA, BY REGION, 2022–2030 (USD MILLION)
    77. GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR GLASS SLIDE AND TUBES, BY REGION,
    78. –2030 (USD MILLION)
    79. FOR CASSETTE/KIT, BY REGION, 2022–2030 (USD MILLION)
    80. BLOOD GROUPING REAGENTS MARKET, FOR OTHER SEROLOGY, BY REGION, 2022–2030 (USD
    81. MILLION)
    82. BY REGION, 2022–2030 (USD MILLION)
    83. MARKET, BY TEST TYPE, 2022–2030 (USD MILLION)
    84. GROUPING REAGENTS MARKET, FOR BLOOD GROUP AND PHENOTYPE, BY REGION, 2022–2030
    85. (USD MILLION)
    86. SCREENING, BY REGION, 2022–2030 (USD MILLION)
    87. GROUPING REAGENTS MARKET, FOR CROSS-MATCHING TESTS, BY REGION, 2022–2030 (USD
    88. MILLION)
    89. BY REGION, 2022–2030 (USD MILLION)
    90. MARKET, FOR COOMBS TESTS, BY REGION, 2022–2030 (USD MILLION)
    91. GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ANTIGEN TYPING, BY REGION, 2022–2030
    92. (USD MILLION)
    93. –2030 (USD MILLION)
    94. FOR HOSPITALS, BY REGION, 2022–2030 (USD MILLION)
    95. GROUPING REAGENTS MARKET, FOR BLOOD BANKS, BY REGION, 2022–2030 (USD MILLION)
    96. REGION, 2022–2030 (USD MILLION)
    97. MARKET, BY REGION, 2022–2030 (USD MILLION)
    98. GROUPING REAGENTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
    99. NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    100. 2030 (USD MILLION)
    101. BY TECHNIQUE, 2022-2030 (USD MILLION)
    102. REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    103. NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    104. (USD MILLION)
    105. (USD MILLION)
    106. BY PRODUCT, 2022-2030 (USD MILLION)
    107. BY TECHNIQUE, 2022-2030 (USD MILLION)
    108. MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    109. GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    110. BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    111. CANADA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    112. (USD MILLION)
    113. 2030 (USD MILLION)
    114. SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    115. REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    116. GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    117. BLOOD GROUPING REAGENTS MARKET, BY COUNTRY, 2022–2030 (USD MILLION)
    118. EUROPE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    119. (USD MILLION)
    120. 2030 (USD MILLION)
    121. SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    122. REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    123. GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    124. BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    125. GERMANY: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD
    126. MILLION)
    127. (USD MILLION)
    128. BY TECHNIQUE, 2022-2030 (USD MILLION)
    129. MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    130. REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    131. REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    132. REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    133. UK: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
    134. (USD MILLION)
    135. (USD MILLION)
    136. (USD MILLION)
    137. 2030 (USD MILLION)
    138. INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    139. REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
    140. GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    141. MILLION)
    142. (USD MILLION)
    143. (USD MILLION)
    144. BY PRODUCT, 2022-2030 (USD MILLION)
    145. MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
    146. REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    147. SPAIN: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    148. (USD MILLION)
    149. 2030 (USD MILLION)
    150. SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    151. REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    152. GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    153. OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    154. 2030 (USD MILLION)
    155. BY TECHNIQUE, 2022-2030 (USD MILLION)
    156. REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    157. REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    158. (USD MILLION)
    159. –2030 (USD MILLION)
    160. MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    161. REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    162. ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
    163. 2030 (USD MILLION)
    164. BY TEST TYPE, 2022-2030 (USD MILLION)
    165. REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    166. GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    167. BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    168. MILLION)
    169. 2030 (USD MILLION)
    170. TEST TYPE, 2022-2030 (USD MILLION)
    171. MARKET, BY END USER, 2022-2030 (USD MILLION)
    172. REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    173. GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    174. MILLION)
    175. 2030 (USD MILLION)
    176. TEST TYPE, 2022-2030 (USD MILLION)
    177. MARKET, BY END USER, 2022-2030 (USD MILLION)
    178. REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    179. GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    180. MILLION)
    181. 2030 (USD MILLION)
    182. TEST TYPE, 2022-2030 (USD MILLION)
    183. MARKET, BY END USER, 2022-2030 (USD MILLION)
    184. REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    185. BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    186. (USD MILLION)
    187. BY TECHNIQUE, 2022-2030 (USD MILLION)
    188. REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    189. BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    190. AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    191. 2030 (USD MILLION)
    192. BY TECHNIQUE, 2022-2030 (USD MILLION)
    193. MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    194. BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    195. AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    196. (USD MILLION)
    197. FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    198. BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
    199. REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE,
    200. 2030 (USD MILLION)
    201. MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    202. BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    203. REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY REGION, 2022–2030
    204. (USD MILLION)
    205. BY PRODUCT, 2022-2030 (USD MILLION)
    206. REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    207. REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD
    208. MILLION)
    209. BY TECHNIQUE, 2022-2030 (USD MILLION)
    210. REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    211. WORLD: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2022-2030 (USD MILLION)
    212. MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2022-2030 (USD MILLION)
    213. 2030 (USD MILLION)
    214. BY TECHNIQUE, 2022-2030 (USD MILLION)
    215. REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    216. MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2022-2030 (USD MILLION)
    217. (USD MILLION)
    218. 2030 (USD MILLION)
    219. INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    220. REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
    221. GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030 (USD MILLION)
    222. MILLION)
    223. (USD MILLION)
    224. 2030 (USD MILLION)
    225. FOR INSTRUMENTS, BY PRODUCT, 2022-2030 (USD MILLION)
    226. BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2022-2030 (USD MILLION)
    227. LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2022-2030
    228. (USD MILLION)
    229. TYPE, 2022-2030 (USD MILLION)
    230. MARKET, BY END USER, 2022-2030 (USD MILLION)
    231. GLOBAL BLOOD GROUPING REAGENTS MARKET
    232. THE GLOBAL BLOOD GROUPING REAGENTS MARKET
    233. KGAA: PRODUCTS OFFERED
    234. BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
    235. OFFERED
    236. COULTER, INC.: KEY DEVELOPMENTS
    237. DAY MEDICAL SA: PRODUCTS/TECHNOLOGIES OFFERED
    238. OFFERED
    239. DIAGAST SAS: PRODUCTS/SERVICES OFFERED
    240. OFFERED
    241. LTD: PRODUCTS/SERVICES OFFERED
    242. PRODUCTS/SERVICES OFFERED
    243. GLOBAL BLOOD GROUPING REAGENTS MARKET
    244. DRIVERS: IMPACT ANALYSIS
    245. VALUE CHAIN: GLOBAL BLOOD GROUPING REAGENTS MARKET
    246. ANALYSIS: GLOBAL BLOOD GROUPING REAGENTS MARKET
    247. REAGENTS MARKET, BY PRODUCT, 2020 & 2030 (USD MILLION)
    248. BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2020 & 2030 (USD MILLION)
    249. GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2020 & 2030 (USD MILLION)
    250. (USD MILLION)
    251. & 2030 (USD MILLION)
    252. SHARE (%), BY COUNTRY 2020 (%)
    253. SHARE (%), BY COUNTRY, 2020
    254. MARKET SHARE (%), BY COUNTRY, 2020
    255. REAGENTS MARKET SHARE (%), BY REGION, 2020
    256. BY KEY PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET
    257. OF MAJOR COMPETITORS
    258. MAJOR PLAYERS R&D EXPENDITURE 2020
    259. SNAPSHOT
    260. INC.: FINANCIAL OVERVIEW SNAPSHOT
    261. ANALYSIS
    262. ORTHO CLINICAL DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT
    263. DIAGNOSTICS: SWOT ANALYSIS
    264. SWOT ANALYSIS

    Blood Grouping Reagents Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Blood Grouping Reagents Market Research Report - Global Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027